Hit Discovery Constance Overview

  • Founded
  • 2013

  • Status
  • Acquired/​Merged

  • Employees
  • 7

  • Latest Deal Type
  • M&A

Hit Discovery Constance General Information


Developer of a compound management platform designed to help pharmaceutical, biotechnology, and academic institutions in Germany and around the world. The company's platform offers a fully integrated service including cost-effective design, optimization, and validation of screening assays and running the entire screening campaign with all required compound logistics, enabling life science industries to get all their compound management needs to be fulfilled.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Primary Office
  • By-Gulden-Straße 2
  • 78467 Konstanz
  • Germany
+49 07531 0000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hit Discovery Constance Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 12-Jan-2022 Completed Generating Revenue
1. Joint Venture 01-Jan-2013 Completed Startup
To view Hit Discovery Constance’s complete valuation and funding history, request access »

Hit Discovery Constance Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hit Discovery Constance Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
KU Leuven Research & Development Venture Capital Minority 000 0000 000000 0
Lead Discovery Center Corporation Minority 000 0000 000000 0
To view Hit Discovery Constance’s complete investors history, request access »